Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery
- PMID: 2149493
- PMCID: PMC171908
- DOI: 10.1128/AAC.34.9.1699
Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery
Abstract
The concentrations of teicoplanin in sera and heart tissues of 49 patients undergoing coronary bypass were measured. Each patient received a 6- or 12-mg/kg dose of teicoplanin administered in a slow intravenous bolus injection over 3 to 5 min beginning at the time of induction of anesthesia. Mean +/- standard error of the mean concentrations in serum were, for the two doses, respectively, 58.1 +/- 1.7 and 123.3 +/- 7.4 micrograms/ml 5 min after administration and 22.2 +/- 0.7 and 56.5 +/- 2.8 micrograms/ml at the time of removal of atrial appendages. Mean +/- standard error of the mean concentrations in tissue were 70.6 +/- 1.7 and 139.8 +/- 2.2 micrograms/g, respectively, giving mean tissue/serum ratios of 3.7 +/- 0.3 and 2.8 +/- 0.2, respectively. Teicoplanin penetrates heart tissue readily and reaches levels in the serum far in excess of the MICs for most pathogens that have been found to cause infections following open heart surgery.
Similar articles
-
Teicoplanin: Part 1. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic lower limb following a single intravenous bolus.Drugs Exp Clin Res. 1989;15(1):21-3. Drugs Exp Clin Res. 1989. PMID: 2526008 Clinical Trial.
-
Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.Antimicrob Agents Chemother. 1997 May;41(5):1150-5. doi: 10.1128/AAC.41.5.1150. Antimicrob Agents Chemother. 1997. PMID: 9145887 Free PMC article. Clinical Trial.
-
Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.Int J Clin Pharmacol Res. 1989;9(4):287-92. Int J Clin Pharmacol Res. 1989. PMID: 2528510
-
Clinical pharmacokinetics of teicoplanin.Clin Pharmacokinet. 1990 Mar;18(3):184-209. doi: 10.2165/00003088-199018030-00002. Clin Pharmacokinet. 1990. PMID: 2138946 Review.
-
Teicoplanin--a new agent for gram-positive bacterial infections.Infect Control Hosp Epidemiol. 1988 May;9(5):209-11. doi: 10.1086/645836. Infect Control Hosp Epidemiol. 1988. PMID: 2967322 Review. No abstract available.
Cited by
-
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008. Drugs. 1994. PMID: 7520860 Review.
-
Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty.Antimicrob Agents Chemother. 2015 Feb;59(2):831-7. doi: 10.1128/AAC.03949-14. Epub 2014 Nov 17. Antimicrob Agents Chemother. 2015. PMID: 25403662 Free PMC article.
-
Teicoplanin-A New Use for an Old Drug in the COVID-19 Era?Pharmaceuticals (Basel). 2021 Nov 26;14(12):1227. doi: 10.3390/ph14121227. Pharmaceuticals (Basel). 2021. PMID: 34959628 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical